Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Abraxis BioScience | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Abraxis BioScience

Mary Lynne Hedley, Ph.D. has been appointed executive vice president of operations and chief scientific officer of Abraxis BioScience.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Mary Lynne Hedley, Ph.D. has been appointed executive vice president of operations and chief scientific officer of Abraxis BioScience. Dr. Hedley most recently served as executive vice president of Eisai Corp. of North America following Eisai’s acquisition of MGI Pharma, where she had served as executive vice president and chief scientific officer since 2005. She joined MGI in 2004 as senior vice president and general manager. Previously, Dr. Hedley co-founded Zycos, Inc., a biotechnology company, and held roles of progressively greater responsibility ultimately leading to her serving as the company’s president and chief executive officer.

“Mary Lynne is an exemplary leader with a strong track record of driving the growth of biotechnology companies,” said Lonnie Moulder, president and chief executive officer of Abraxis. “Her general management and R&D leadership experience, coupled with a deep scientific background, make her an ideal addition to our executive team. We are very pleased to have this experienced executive join Abraxis as we advance our mission to enhance the lives of cancer patients throughout the world.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters